Learning From Errors: Response to Gefitinib in Kidney Urothelial Carcinoma With EGFR Mutations

Oncologist - United States
doi 10.1634/theoncologist.2013-0346
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Erlotinib Has Better Efficacy Than Gefitinib in Adenocarcinoma Patients Without EGFR-activating Mutations, but Similar Efficacy in Patients With EGFR-activating Mutations

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2011English

P1.01-20 Phase III Study Comparing Gefitinib (G) to Gefitinib Combined With Carboplatin and Pemetrexed (GCP) for NSCLC With EGFR Mutations (NEJ009)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

Central Nervous System Progression in Advanced Non–small Cell Lung Cancer Patients With EGFR Mutations in Response to First-Line Treatment With Two EGFR-TKIs, Gefitinib and Erlotinib: A Comparative Study

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

EGFR Exon 19 Insertions Show Good Response to Gefitinib, but Short Time to Progression in Japanese Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Metabolic Complete Response With Vinflunine as Second-Line Therapy in a Kidney-Transplanted Patient With Advanced Urothelial Carcinoma: A Case Report

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Activation of the BMP-BMPR Pathway Conferred Resistance to EGFR-TKIs in Lung Squamous Cell Carcinoma Patients With EGFR Mutations

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2016English

P3.13-08 Assessment of EGFR Gene Mutations in Cf-Dna in Monitoring of Response to EGFR TKIs in Patients With Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy